Erfanian Hamid's Form 4 filing
Enzo Biochem Inc (ENZB) · filed Jun 17, 2022
- Accession no.
- 0001213900-22-033623
- Filed
- Jun 17, 2022
- Trade date
- Nov 8, 2021-Jun 15, 2022
- Filing delay
- 221 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 1 derivative transaction. Open-market purchases total $10.1K. It was filed 221 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Erfanian HamidCIK 0001893172 | Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 15, 2022 | Common Stock, $0.01 Par Value | PPurchaseAcquired | +4,600 | $2.19 | +$10,074 | 274,600 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 8, 2021 | Common Stock | AGrant or awardAcquired | +700,000 | $0.00 | $0 | 700,000 | Direct | Duplicate filing |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.